Elicio Therapeutics (ELTX) Times Interest Earned (2022 - 2026)
Elicio Therapeutics posted quarterly Times Interest Earned of -$26.05 for Q1 2026, up 57.3% year-on-year from -$16.56 in Q1 2025, and up 0.72% on a QoQ basis from -$26.24 in Q4 2025.
Elicio Therapeutics (ELTX) has 5 years of Times Interest Earned data on file, last reported at -$26.05 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 57.3% year-over-year to -$26.05; the trailing twelve-month figure through Mar 2026 stood at -$27.55 (up 63.89% YoY), and the FY2025 full-year result was -$33.29, up 66.33% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$26.05, up from -$26.24 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$5.35 in Q3 2022 and bottomed at -$10771.0 in Q3 2023.
- The 5-year median for Times Interest Earned is -$54.8 (2024), against an average of -$1025.1.
- The widest annual swing landed in 2023, when Times Interest Earned slumped 201132.89%; it then soared 99.3% in 2024.
- A 5-year view of Times Interest Earned shows it stood at -$64.79 in 2022, then tumbled by 7147.64% to -$4696.0 in 2023, then jumped by 98.77% to -$57.59 in 2024, then jumped by 54.44% to -$26.24 in 2025, then advanced by 0.72% to -$26.05 in 2026.
- The last three Times Interest Earned figures came in at -$26.05 (Q1 2026), -$26.24 (Q4 2025), and -$18.88 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | Elicio Therapeutics | 217.63 Mn | 202.68 Mn | - | -26.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.05 |
| Dec 31, 2025 | -26.24 |
| Sep 30, 2025 | -18.88 |
| Jun 30, 2025 | -52.02 |
| Mar 31, 2025 | -61.00 |
| Dec 31, 2024 | -57.59 |
| Sep 30, 2024 | -75.50 |
| Jun 30, 2024 | -222.94 |
| Mar 31, 2024 | -284.47 |
| Dec 31, 2023 | -4,696.00 |
| Sep 30, 2023 | -10,771.00 |
| Jun 30, 2023 | -10.89 |
| Mar 31, 2023 | -22.82 |
| Dec 31, 2022 | -64.79 |
| Sep 30, 2022 | -5.35 |
| Jun 30, 2022 | -5.84 |